| |
Synergy Group - True Hope or True Hype?E M POWER+ DIETARY SUPPLEMENT This is what you ingest per day at the recommended therapeutic dosage, also called the loading dose, of 32 capsules daily. UL: Upper Tolerable Intake Level: "The highest daily average nutrient intake level that is likely to pose no risk of adverse health effects to almost all individuals in the general population. As intake increases above the UL, the potential risk of adverse effects may increase." Ingredients marked with a
Ingredients marked with an asterisk * make up the Proprietary CNS Blend. Though not disclosed on the label, the Proprietary CNS Blend has been in the public domain since October 2000, when it was included in B. Kaplan's poster presentation titled "Successful treatment of bipolar disorder with a nutritional supplement: Ten cases", presented at the annual meeting of the Canadian Psychiatric Association in Vancouver BC. In addition, the full list of ingredients in E M Power+, including the Proprietary CNS Blend, has been posted on Usenet since June 2000. Finally, the Synergy Group of Canada claims: "Synergy does not own the intellectual property rights in these products." [Documents released by Health Canada under the Access to Information Act on 17 May 2002., ATI file number A-2001-0845/ms, notes to pp. 79-80.] *PEOPLE HAVE A RIGHT TO KNOW WHAT THEY ARE PUTTING INTO THEIR BODIES* Vanadium, nickel and boron are disclosed because ULs exist for these minerals, and the amount of vanadium exceeds the UL. Germanium is disclosed because of concerns raised by Synergy Group of Canada associates regarding the form of germanium: it seems they are correct - germanium sesquioxide appears to be safe. Choline is disclosed because it too has a UL; methionine is an active substance, and so is disclosed, as are glutamine and phenylalanine.
Moreover, persons diagnosed with schizophrenia may wish to avoid phenylalanine altogether in view of: Richardson MA, Reilly MA, Read LL, Flynn CJ, Suckow RF, Maher TJ, Sziraki I. "Phenylalanine kinetics are associated with tardive dyskinesia in men but not in women." Psychopharmacology (Berl). 1999 Apr;143(4):347-57; and Janssen PA, Leysen JE, Megens AA, Awouters FH. "Does phenylethylamine act as an endogenous amphetamine in some patients?" Int J Neuropsychopharmacol. 1999 Sep;2(3):229-240.
Here is information on the ingredients in E M Power+ offered by the Synergy Group of Canada: http://www.truehope.com/publications/profile.htm.
|
exceed the Upper Tolerable Intake Levels set by the Institute of Medicine for adults. This could increase the potential health risks from adverse events, especially for children.